This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
SYNLAB Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
SYNLAB has a total shareholder equity of €2.4B and total debt of €924.8M, which brings its debt-to-equity ratio to 39%. Its total assets and total liabilities are €4.7B and €2.3B respectively. SYNLAB's EBIT is €151.2M making its interest coverage ratio 1.8. It has cash and short-term investments of €300.5M.
Anahtar bilgiler
39.0%
Borç/özkaynak oranı
€924.83m
Borç
| Faiz karşılama oranı | 1.8x |
| Nakit | €300.47m |
| Eşitlik | €2.37b |
| Toplam yükümlülükler | €2.34b |
| Toplam varlıklar | €4.71b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
SYNLAB (FRA:SYAB) Might Have The Makings Of A Multi-Bagger
Dec 15
Returns Are Gaining Momentum At SYNLAB (FRA:SYAB)
Sep 10SYNLAB AG (FRA:SYAB) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 14SYNLAB AG (FRA:SYAB) Stock Catapults 27% Though Its Price And Business Still Lag The Market
May 29SYNLAB (FRA:SYAB) Is Investing Its Capital With Increasing Efficiency
May 20Are Investors Undervaluing SYNLAB AG (FRA:SYAB) By 25%?
Sep 26Shareholders Will Be Pleased With The Quality of SYNLAB's (FRA:SYAB) Earnings
Aug 22Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SYAB's short term assets (€860.3M) exceed its short term liabilities (€693.9M).
Uzun Vadeli Yükümlülükler: SYAB's short term assets (€860.3M) do not cover its long term liabilities (€1.6B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SYAB's net debt to equity ratio (26.3%) is considered satisfactory.
Borcun Azaltılması: SYAB's debt to equity ratio has reduced from 248.8% to 39% over the past 5 years.
Borç Kapsamı: SYAB's debt is well covered by operating cash flow (45.3%).
Faiz Kapsamı: SYAB's interest payments on its debt are not well covered by EBIT (1.8x coverage).